Value of Neutrophil to Lymphocyte Ratio and Its Trajectory in Patients Hospitalized With Acute Heart Failure and Preserved Ejection Fraction
- 1 January 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 125 (2) , 229-235
Abstract
No abstract availableKeywords
Funding Information
- Intermountain Healthcare
- Intermountain Research and Medical Foundation
- North Carolina GlaxoSmithKline Foundation
- AstraZeneca
This publication has 25 references indexed in Scilit:
- Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failureJournal of Cardiology, 2014
- Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection FractionCirculation, 2012
- Get With The Guidelines Program Participation, Process of Care, and Outcome for Medicare Patients Hospitalized With Heart FailureCirculation: Cardiovascular Quality and Outcomes, 2012
- Utility of the Neutrophil to Lymphocyte Ratio in Predicting Long-Term Outcomes in Acute Decompensated Heart FailureThe American Journal of Cardiology, 2011
- A Validated Risk Score for In-Hospital Mortality in Patients With Heart Failure From the American Heart Association Get With the Guidelines ProgramCirculation: Cardiovascular Quality and Outcomes, 2010
- Red Cell Distribution Width as a Novel Prognostic Marker in Heart FailureJACC, 2007
- Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based StudyNew England Journal of Medicine, 2006
- Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?JACC, 2005
- The American Heart Association get with the guidelines programAmerican Heart Journal, 2004
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003